Beckman.com is conducting maintenance Saturday, September 19th and Sunday, September 20th. Parts of the site may have limited accessibility throughout the weekend. During this time, orders can still be placed by calling Client Services. We look forward to providing an improved customer experience. Beckman.com will return Monday, September 21st.
What are some of the ways CRISPR can enhance improved therapeutic agents?
Combining CRISPR with conventional pharmaceutical agents can be more effective than using the traditional therapeutic options by themselves. CRISPR has rapidly accelerated drug discovery, identification, and preclinical validation, whether by modifying cells to mimic human pathophysiological conditions, generating screens, or developing transgenic animal models. CRISPR-based immunotherapeutics is being tested for the treatment of cancers, as well as a variety of genetically predisposed conditions including sickle cell anemia. With advances in genome sequencing, it is conceivable to envision a customized treatment plan where DNA-editing drugs are prescribed to a patient to target genome sequencing-revealed mutations. For more information on CRISPR visit our resource center here.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.